Report error Found 32 of ic50 data for polymerid = 50006054
Affinity DataIC50: 4.27nMAssay Description:Agonist activity at RXFP3 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 6 hrs by beta galactosidase r...More data for this Ligand-Target Pair
Affinity DataIC50: 5.13nMAssay Description:Agonist activity at RXFP3 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 6 hrs by beta galactosidase r...More data for this Ligand-Target Pair
Affinity DataIC50: 12.6nMAssay Description:Agonist activity at RXFP3 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 6 hrs by beta galactosidase r...More data for this Ligand-Target Pair
Affinity DataIC50: 504nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 561nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as inhibition of relaxin-3 stimulated ERK1/2 phosphorylation preincubated for 1...More data for this Ligand-Target Pair
Affinity DataIC50: 1.49E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 2.12E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 2.12E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 2.67E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 3.04E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as [35S]GTPgammaS binding incubated for 1 hr by [35S]GTP-gammaS binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.08E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 4.04E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 4.34E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 4.52E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as [35S]GTPgammaS binding incubated for 1 hr by [35S]GTP-gammaS binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.72E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 4.78E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as [35S]GTPgammaS binding incubated for 1 hr by [35S]GTP-gammaS binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.95E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 5.28E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 5.74E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 6.13E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 6.98E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 7.69E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 7.80E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 7.82E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as inhibition of relaxin-3 stimulated ERK1/2 phosphorylation preincubated for 1...More data for this Ligand-Target Pair
Affinity DataIC50: 7.90E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 8.51E+3nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation measured after 30 mins in presence of re...More data for this Ligand-Target Pair
Affinity DataIC50: 1.39E+4nMAssay Description:Antagonist activity at human RXFP3 expressed in CHO-K1 cells assessed as inhibition of relaxin-3 stimulated ERK1/2 phosphorylation preincubated for 1...More data for this Ligand-Target Pair
